Product Name | Anisomycin |
Description |
p38 MAP kinase activator |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Solubility | Soluble to 100 mM in DMSO and to 100 mM in ethanol |
Appearance | White solid |
Safety Phrases |
Classification: Toxic. May be harmful or fatal if inhaled, swallowed or absorbed through skin. Safety Phrases: S22 - Do not breathe dust S24/25 - Avoid contact with skin and eyes S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible) Risk Phrases: R23/24/25 - Toxic by inhilation, in contact with skin and if swallowed Hazard Phrases: H301 Precautionary Phrases: P301 + P310 |
Cite This Product | Anisomycin (StressMarq Biosciences, Canada, Cat # SIH-266) |
Alternative Names | (2S,3R,4R)-4-Hydroxy-2-(4-methoxybenzyl)-3-pyrrolidinyl acetate |
Scientific Background | Anisomycin is an antibiotic which inhibits protein synthesis (1). It interferes with protein and DNA synthesis by inhibiting peptidyl transferace on the 80S ribosome system. It can activate stress-activated protein kinases, MAPkinase and other signal transduction pathways. |
References | 1. Grollman A.P. (1967) J Biol Chem. 242(13): 3226-3233. |
StressMarq Biosciences :
Based on validation through cited publications.